Literature DB >> 28188292

Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity.

Hung-Ching Hsia1,2, Jessica E Hutti2, Albert S Baldwin3,2.   

Abstract

Cytosolic DNA can elicit beneficial as well as undesirable immune responses. For example, viral or microbial DNA triggers cell-intrinsic immune responses to defend against infections, whereas aberrant cytosolic accumulation of self-DNA results in pathological conditions, such as autoimmunity. Given the importance of these DNA-provoked responses, a better understanding of their molecular mechanisms is needed. Cytosolic DNA engages stimulator of interferon genes (STING) to activate TANK-binding kinase 1 (TBK1), which subsequently phosphorylates the transcription factor interferon regulatory factor 3 (IRF3) to promote interferon expression. Recent studies have reported that additional transcription factors, including nuclear factor κB (NF-κB) and signal transducer and activator of transcription 6 (STAT6), are also activated by cytosolic DNA, suggesting that cytosolic DNA-induced gene expression is orchestrated by multiple factors. Here we show that cytosolic DNA activates STAT3, another member of the STAT family, via an autocrine mechanism involving interferon β (IFNβ) and IL-6. Additionally, we observed a novel cytosolic DNA-induced phosphorylation at serine 754 in the transactivation domain of STAT3. Upon cytosolic DNA stimulation, Ser754 is directly phosphorylated by TBK1 in a STING-dependent manner. Moreover, Ser754 phosphorylation inhibits cytosolic DNA-induced STAT3 transcriptional activity and selectively reduces STAT3 target genes that are up-regulated in response to cytosolic DNA. Taken together, our results suggest that cytosolic DNA-induced STAT3 activation via IFNβ and IL-6 is restrained by Ser754 phosphorylation of STAT3. Our findings reveal a new signaling axis downstream of the cytosolic DNA pathway and suggest potential interactions between innate immune responses and STAT3-driven oncogenic pathways.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cytosolic DNA; STAT transcription factor; STAT3; STING; TBK1; cell signaling; innate immunity; phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28188292      PMCID: PMC5392684          DOI: 10.1074/jbc.M116.771964

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases.

Authors:  Tao Wang; Michael A Block; Scott Cowen; Audrey M Davies; Erik Devereaux; Lakshmaiah Gingipalli; Jeffrey Johannes; Nicholas A Larsen; Qibin Su; Julie A Tucker; David Whitston; Jiaquan Wu; Hai-Jun Zhang; Michael Zinda; Claudio Chuaqui
Journal:  Bioorg Med Chem Lett       Date:  2012-01-14       Impact factor: 2.823

2.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

3.  Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.

Authors:  Takayuki Abe; Glen N Barber
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 4.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

5.  Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis.

Authors:  Tianli Xia; Hiroyasu Konno; Jeonghyun Ahn; Glen N Barber
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423

Review 6.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

7.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

Review 8.  STATs get their move on.

Authors:  Nancy C Reich
Journal:  JAKSTAT       Date:  2013-11-13

9.  Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKε.

Authors:  Jessica E Hutti; Melissa A Porter; Adam W Cheely; Lewis C Cantley; Xiaodong Wang; Dmitri Kireev; Albert S Baldwin; William P Janzen
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Cell type-specific subcellular localization of phospho-TBK1 in response to cytoplasmic viral DNA.

Authors:  Takayuki Suzuki; Hiroyuki Oshiumi; Moeko Miyashita; Hussein Hassan Aly; Misako Matsumoto; Tsukasa Seya
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more
  11 in total

1.  Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2.

Authors:  Matthew Tegowski; Cheng Fan; Albert S Baldwin
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

Review 2.  Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  TRIM14 Is a Key Regulator of the Type I IFN Response during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn T Hoffpauir; Samantha L Bell; Kelsi O West; Tao Jing; Allison R Wagner; Sylvia Torres-Odio; Jeffery S Cox; A Phillip West; Pingwei Li; Kristin L Patrick; Robert O Watson
Journal:  J Immunol       Date:  2020-05-13       Impact factor: 5.422

4.  TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877.

Authors:  Ricardo J Antonia; Johnny Castillo; Laura E Herring; D Stephen Serafin; Pengda Liu; Lee M Graves; Albert S Baldwin; Robert S Hagan
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

Review 5.  Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19.

Authors:  Shahab Mahmoudvand; Somayeh Shokri
Journal:  Scand J Immunol       Date:  2021-08-10       Impact factor: 3.889

6.  Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling.

Authors:  Jiajia Wang; Jiaying Wang; Wenxiang Hong; Lulu Zhang; Liqian Song; Qi Shi; Yanfei Shao; Guifeng Hao; Chunyan Fang; Yueping Qiu; Lijun Yang; Zhaoxu Yang; Jincheng Wang; Ji Cao; Bo Yang; Qiaojun He; Qinjie Weng
Journal:  Nat Commun       Date:  2021-10-27       Impact factor: 14.919

Review 7.  Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer.

Authors:  Joel K Durand; Qing Zhang; Albert S Baldwin
Journal:  Cells       Date:  2018-09-15       Impact factor: 6.600

8.  Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk.

Authors:  Calogerina Catalano; Miguel Inacio da Silva Filho; Christoph Frank; Shun Lu; Katerina Jiraskova; Veronika Vymetalkova; Miroslav Levy; Vaclav Liska; Ondrej Vycital; Alessio Naccarati; Ludmila Vodickova; Kari Hemminki; Pavel Vodicka; Alexander N R Weber; Asta Försti
Journal:  Cancer Med       Date:  2019-12-23       Impact factor: 4.452

Review 9.  Targeting STAT3 in Cancer Immunotherapy.

Authors:  Sailan Zou; Qiyu Tong; Bowen Liu; Wei Huang; Yan Tian; Xianghui Fu
Journal:  Mol Cancer       Date:  2020-09-24       Impact factor: 27.401

10.  Transfection of STAT3 overexpression plasmid mediated through recombinant lentivirus promotes differentiation of bone marrow mesenchymal stem cells into neural cells in fetal rats with spina bifida aperta.

Authors:  Mingyu Jiang; Jiale Feng; Rong Fu; Yanbo Pan; Xu Liu; Jicheng Dai; Chunming Jiang; Yunpeng Hao; Mingyong Ren
Journal:  Aging (Albany NY)       Date:  2021-09-14       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.